Iztok Hozo

Economics, Econometrics and FinanceDecision SciencesMathematicsHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Optimal type I and type II error pairs when the available sample size is fixed”.

Optimal type I and type II error pairs when the available sample size is fixed

Journal of Clinical Epidemiology(2013)10.1016/j.jclinepi.2013.03.002

N/A

0.524DataRank · unranked

32 citations

Iztok Hozo, John P. A. Ioannidis, Benjamin Djulbegović

Modern health care as a game theory problem

European Journal of Clinical Investigation(2014)10.1111/eci.12380

N/A

0.494DataRank · unranked

26 citations

Iztok Hozo, Benjamin Djulbegović, John P. A. Ioannidis

Improving the Drug Development Process

JAMA(2014)10.1001/jama.2013.283742

N/A

0.489DataRank · unranked

25 citations

Iztok Hozo, John P. A. Ioannidis, Benjamin Djulbegović

Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible

Journal of Clinical Epidemiology(2022)10.1016/j.jclinepi.2022.01.016

N/A

0.360DataRank · unranked

10 citations

Benjamin Djulbegović, Austin J. Parish, John P. A. Ioannidis, Iztok Hozo

Federal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.45590

N/A

0.330DataRank · unranked

8 citations

Iztok Hozo, Benjamin Djulbegović, John P. A. Ioannidis

There is no upper limit on the maximum effect that can be detected in randomized trials

Journal of Clinical Epidemiology(2025)10.1016/j.jclinepi.2025.111828

N/A

0.223DataRank · unranked

3 citations

Iztok Hozo, Renata Iskander, Austin J. Parish, Jonathan Kimmelman, Benjamin Djulbegović +1 more

Modern health care as a game theory problem: reply

European Journal of Clinical Investigation(2015)10.1111/eci.12414

N/A

0.208DataRank · unranked

3 citations

Iztok Hozo, Benjamin Djulbegović, John P. A. Ioannidis

Theory of clinical therapeutic progress: reconciling equipoise with fat-tailed (skewed) outcomes

Journal of Clinical Epidemiology(2025)10.1016/j.jclinepi.2025.112004

N/A

0DataRank · unranked

0 citations

Benjamin Djulbegović, Iztok Hozo

Progress in Cancer Therapeutics: Is There an Upper Limit on the Maximum Effect that Can Be Detected in Randomized Trials

SSRN Electronic Journal(2025)10.2139/ssrn.5159364

N/A

0DataRank · unranked

0 citations

Iztok Hozo, Renata Iskander, Austin J. Parish, Jonathan Kimmelman, John P. A. Ioannidis +2 more

Study Design and the Drug Development Process—Reply

JAMA(2014)10.1001/jama.2014.3829

N/A

0DataRank · unranked

0 citations

Iztok Hozo, Benjamin Djulbegović, John P. A. Ioannidis

Federal Funding and Citation Metrics of Biomedical Research in the USA

medRxiv(2022)10.1101/2022.08.31.22279467

N/A

0DataRank · unranked

0 citations

Iztok Hozo, Benjamin Djulbegović, John P. A. Ioannidis